Fatima Mustafa Lakdawala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Fatima Mustafa Lakdawala has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Alizeh Imran
Ziauddin Medical University Karachi Pakistan
3 shared publications - Ahad Yousuf Moulvi
Ziauddin University, Karachi, Pakistan
1 shared publication - Aroosa Roshan
Dow International Medical College, Dow University of Health Sciences, Karachi, Sindh, 74200, Pakistan
1 shared publication - David Tuchman
Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Sinai Hospital, Baltimore, USA
1 shared publication - Fatima Azam
Dow International Medical College, Dow University of Health Sciences, Karachi, Sindh, 74200, Pakistan
1 shared publication - Ifrah Salim
Ziauddin Medical College, Karachi, Sindh, 75000, Pakistan
1 shared publication
Latest Publications
- Open Access
- 1 June 2025
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 74 (06) , 1039
Remarkable findings in male pattern baldness: sugar molecule 2dDR offers hope for hair regrowth
Dear Madam, Hair-loss, particularly androgenic alopecia (AGA) currently plagues over half the population worldwide(1), affecting their self-esteem. Alarmingly, hair-loss has doubled in the paediatric population with trends only increasing among younger individuals(2). The lack of approved, evidence-based, cost effective and low side-effect therapies has led people to social media platforms like TikTok, where they experiment with natural remedies like rosemary oil and rice water which lack standardisation and may do more harm than good (3). It is therefore imperative to find more painless and affordable solutions to hair loss for which 2dDR-SA (2-deoxy-D-ribose sodium alginate) hydrogel may offer hope. Currently there are only 2 FDA approved therapies for androgenic alopecia: topical Minoxidil and oral finasteride of which finasteride is contraindicated in premenopausal women and classified as pregnancy category X. However, there are multiple therapies being used off-label to treat AGA, with varying efficacies, delivery mechanisms, safety profiles and price points. Oral therapies include minoxidil, dutasteride, spironolactone, flutamide and bicalutamide, and cyproterone acetate. While topical therapies include clascoterone and pyrilutamide. In-office treatments such as low-level light therapy, intradermal botulinum toxin, dutasteride mesotherapy, platelet-rich plasma (PRP), mesenchymal stem cells exosomes and microneedling can be quite expensive, require multiple sessions and may cause pain.(4) For patients troubled by the side effects, low efficacy or priciness of these therapies, the discovery of 2dDR-SA hydrogel presents a potentially low-cost alternative. What started off as experimentation with 2dDR for the purposes of wound healing due to properties similar to vascular endothelial growth factor (VEGF), resulted in intriguing findings of hair regrowth at the wound site. This prompted Anjum et al. (2024) affiliated with COMSATS University in Islamabad to explore this mechanism further by preparing a hydrogel comprising 2dDR, sodium alginate, and other stabilisers to release the sugar slowly onto mice. These mice had been injected with testosterone to mimic AGA and showed positive results after 21 days. The 2dDR-SA hydrogel-treated mice showed a similar level of hair regrowth as the minoxidil control group accompanied by observations such as increased hair follicle density and length, stimulation of angiogenesis, and enhanced melanin synthesis. The working hypothesis is that 2dDR stimulates VEGF and thereby, angiogenesis, promoting new hair growth.(5) This is a compelling hypothesis that sets a novel framework to conduct additional research on the clinical use of 2dDR for AGA and proposes exploring other therapies that stimulate VEGF as potential treatments for alopecia.
- 1 June 2025
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 74 (06) , 1039
Open AccessRemarkable findings in male pattern baldness: sugar molecule 2dDR offers hope for hair regrowth
Dear Madam, Hair-loss, particularly androgenic alopecia (AGA) currently plagues over half the population worldwide(1), affecting their self-esteem. Alarmingly, hair-loss has doubled in the paediatric population with trends only increasing among younger individuals(2). The lack of approved, evidence-based, cost effective and low side-effect therapies has led people to social media platforms like TikTok, where they experiment with natural remedies like rosemary oil and rice water which lack standardisation and may do more harm than good (3). It is therefore imperative to find more painless and affordable solutions to hair loss for which 2dDR-SA (2-deoxy-D-ribose sodium alginate) hydrogel may offer hope. Currently there are only 2 FDA approved therapies for androgenic alopecia: topical Minoxidil and oral finasteride of which finasteride is contraindicated in premenopausal women and classified as pregnancy category X. However, there are multiple therapies being used off-label to treat AGA, with varying efficacies, delivery mechanisms, safety profiles and price points. Oral therapies include minoxidil, dutasteride, spironolactone, flutamide and bicalutamide, and cyproterone acetate. While topical therapies include clascoterone and pyrilutamide. In-office treatments such as low-level light therapy, intradermal botulinum toxin, dutasteride mesotherapy, platelet-rich plasma (PRP), mesenchymal stem cells exosomes and microneedling can be quite expensive, require multiple sessions and may cause pain.(4) For patients troubled by the side effects, low efficacy or priciness of these therapies, the discovery of 2dDR-SA hydrogel presents a potentially low-cost alternative. What started off as experimentation with 2dDR for the purposes of wound healing due to properties similar to vascular endothelial growth factor (VEGF), resulted in intriguing findings of hair regrowth at the wound site. This prompted Anjum et al. (2024) affiliated with COMSATS University in Islamabad to explore this mechanism further by preparing a hydrogel comprising 2dDR, sodium alginate, and other stabilisers to release the sugar slowly onto mice. These mice had been injected with testosterone to mimic AGA and showed positive results after 21 days. The 2dDR-SA hydrogel-treated mice showed a similar level of hair regrowth as the minoxidil control group accompanied by observations such as increased hair follicle density and length, stimulation of angiogenesis, and enhanced melanin synthesis. The working hypothesis is that 2dDR stimulates VEGF and thereby, angiogenesis, promoting new hair growth.(5) This is a compelling hypothesis that sets a novel framework to conduct additional research on the clinical use of 2dDR for AGA and proposes exploring other therapies that stimulate VEGF as potential treatments for alopecia.
- Open Access
- 16 October 2024
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 74 (11) , 2039-2041
Unforeseen severity in a case of neonatal cow milk protein allergy: a case report
Cow milk protein allergy (CMPA) is one of the most common childhood allergies that manifests with a range of digestive symptoms and skin reactions, which usually resolve with age. In this report, we present the case of a one-month-old male who presented with a rare and severe manifestation of neonatal CMPA. The neonate underwent numerous hospital admissions due to a presentation that closely mimicked symptoms of a metabolic disorder and sepsis. Our primary objective is to highlight the significance of systematically considering or excluding a CMPA diagnosis, irrespective of the severity of presentation. This proactive approach may potentially reduce future complications among the affected paediatric population, thereby preventing prolonged hospitalisation and the associated disease burden, as seen in this case. Keywords: Cow milk protein allergy, Metabolic acidosis, Amino-acid based infant formula, Neonatal food allergy, CMPA.
- 16 October 2024
- Published by Pakistan Medical Association in Journal of the Pakistan Medical Association
- Vol. 74 (11) , 2039-2041
Open AccessUnforeseen severity in a case of neonatal cow milk protein allergy: a case report
Cow milk protein allergy (CMPA) is one of the most common childhood allergies that manifests with a range of digestive symptoms and skin reactions, which usually resolve with age. In this report, we present the case of a one-month-old male who presented with a rare and severe manifestation of neonatal CMPA. The neonate underwent numerous hospital admissions due to a presentation that closely mimicked symptoms of a metabolic disorder and sepsis. Our primary objective is to highlight the significance of systematically considering or excluding a CMPA diagnosis, irrespective of the severity of presentation. This proactive approach may potentially reduce future complications among the affected paediatric population, thereby preventing prolonged hospitalisation and the associated disease burden, as seen in this case. Keywords: Cow milk protein allergy, Metabolic acidosis, Amino-acid based infant formula, Neonatal food allergy, CMPA.
- 23 May 2024
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 69 (10) , 3640-3649
A Smooth Transition: Assessing Transition Readiness in Adolescents with Inflammatory Bowel Disease
Background Inflammatory Bowel Disease (IBD) is an early onset condition that affects individuals of all ages. Approximately 15%–25% of patients present before the age of 20 years, with peak onset occurring during adolescence. Aims To evaluate transition readiness among adolescents diagnosed with IBD and identify barriers to transition. Methods We conducted a cross-sectional study of patients with IBD aged 12–21 years. Patients were stratified by age into three groups: A (12–14 years), B (14–17 years), and C (17 + years). Patients were asked to complete a questionnaire which assessed patient knowledge in three areas of transition: ‘Taking Charge,’ ‘My Health,’ and ‘Using Health Care.’ Fisher's Exact and Chi-Square tests were used to evaluate the associations between age and transition readiness. Results A total of 127 participants (68 males and 59 females) with a mean age of 16.14 years were included. Transition readiness increased with age from 60.7% in Group A to 63.2% and 77.9% in Groups B and C, respectively (p < 0.001). Patient confidence and the importance of transition increased with age, with means of 5.51, 6.17, and 6.94 in Groups A, B, and C (p = 0.02). Patient-reported knowledge of their health condition was > 70%, with no statistical differences between the groups (p = 0.65). Patient knowledge regarding ‘Using Health Care’ increased from 52% in Group A to 79% in Group C (p < 0.001). The greatest barriers to transitioning were carrying health information for Group A (100%) and obtaining provider referrals for Groups B (75%) and C (51%). Conclusion This study demonstrated that transition readiness increases with age in adolescents with IBD.
- 23 May 2024
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 69 (10) , 3640-3649
A Smooth Transition: Assessing Transition Readiness in Adolescents with Inflammatory Bowel Disease
Background Inflammatory Bowel Disease (IBD) is an early onset condition that affects individuals of all ages. Approximately 15%–25% of patients present before the age of 20 years, with peak onset occurring during adolescence. Aims To evaluate transition readiness among adolescents diagnosed with IBD and identify barriers to transition. Methods We conducted a cross-sectional study of patients with IBD aged 12–21 years. Patients were stratified by age into three groups: A (12–14 years), B (14–17 years), and C (17 + years). Patients were asked to complete a questionnaire which assessed patient knowledge in three areas of transition: ‘Taking Charge,’ ‘My Health,’ and ‘Using Health Care.’ Fisher's Exact and Chi-Square tests were used to evaluate the associations between age and transition readiness. Results A total of 127 participants (68 males and 59 females) with a mean age of 16.14 years were included. Transition readiness increased with age from 60.7% in Group A to 63.2% and 77.9% in Groups B and C, respectively (p < 0.001). Patient confidence and the importance of transition increased with age, with means of 5.51, 6.17, and 6.94 in Groups A, B, and C (p = 0.02). Patient-reported knowledge of their health condition was > 70%, with no statistical differences between the groups (p = 0.65). Patient knowledge regarding ‘Using Health Care’ increased from 52% in Group A to 79% in Group C (p < 0.001). The greatest barriers to transitioning were carrying health information for Group A (100%) and obtaining provider referrals for Groups B (75%) and C (51%). Conclusion This study demonstrated that transition readiness increases with age in adolescents with IBD.
- Open Access
- 31 January 2024
- Published by Taylor & Francis in Future Science OA
- Vol. 10 (1) , FSO953
A bibliometric analysis of the 100 most-influential papers in the field of anti-diabetic drugs
Aim: We analyzed the 100 most-cited articles on all anti-diabetic drugs. A comprehensive literature review found no bibliometrics on this. Methods: Two researchers independently extracted articles ...
- 31 January 2024
- Published by Taylor & Francis in Future Science OA
- Vol. 10 (1) , FSO953
Open AccessA bibliometric analysis of the 100 most-influential papers in the field of anti-diabetic drugs
Aim: We analyzed the 100 most-cited articles on all anti-diabetic drugs. A comprehensive literature review found no bibliometrics on this. Methods: Two researchers independently extracted articles ...